SP Scientific partners with i-Dositecno, integrates its fill-finish offering

By Vassia Barba contact

- Last updated on GMT

(Image: Getty/RGtimeline)
(Image: Getty/RGtimeline)

Related tags: SP Scientific, fill/finish, Injectables, Sterile Injectables

SP Scientific partners with Spanish i-Dositecno to offer complete aseptic vial and syringe fill-finish lines to clients in Europe and North America.

Pennsylvania, US-based SP Scientific, a company providing freeze-drying and sterilizing services, announced a partnership with i-Dositecno, a developer of aseptic processing systems based in Barcelona, Spain.

Under the partnership, SP Scientific will include i-Dositecno’s vial and syringe filling equipment and capabilities in its offering to provide a full fill-finish line for clients in Europe and North America.

Through this collaboration, the companies aim to “serve the changing biopharmaceutical developers to their exact capacity requirements, as the market migrates to biological drugs,”​ Ian Whitehall, SP Scientific’s CMO, told us.

According to Whitehall, the partnership answers clients’ demands for one-stop fill-finish service, while i-Dositecno’s equipment ‘perfectly’ matches SP Scientific’s small-batch throughput freeze-drying for pharmaceutical injectable products.

As a result of the partnership, SP Scientific is expected to offer “the broadest lyophilization range available today”​ covering cycle development, stability, pilot, and clinical batch production through full aseptic manufacturing and commercial production batches, according to the company.

Furthermore, the development of this full processing line is expected to enable manufacturers to ensure the products’ integrity in the container that holds the medicine during transportation through a variety of global climates.

This is critical for biopharmaceuticals that need to be frozen and then thawed, freeze-dried, rehydrated, or encapsulated in liquid form without being touched by the atmosphere.

Related news

Related products

show more

Q&A: Effective Drug Product Process Development

Q&A: Effective Drug Product Process Development

Catalent Pharma Solutions | 14-Jan-2021 | Insight Guide

In this Q&A, a Catalent Biologics expert shares his expertise with drug product process development challenges, risks and how to mitigate them, the...

Why Blister Packaging: Things to Consider

Why Blister Packaging: Things to Consider

Catalent Pharma Solutions | 03-Dec-2020 | Insight Guide

The decision to use blister packaging for either clinical trials or commercial drug manufacturing comes with a host of factors to consider. Pharmaceutical...

Related suppliers

Follow us


View more